Our Leadership

Our aim is to advance the care of critically ill patients

From our technicians to our CEO, here you’ll find individuals whose actions speak louder than words. People who strive to make a difference in the lives of critically ill patients and the clinicians who care for them.

Executive Team

Daniel Tassé - Chairman and Chief Executive Officer

Daniel Tassé - Chairman and Chief Executive Officer

“When people become critically ill, their entire world changes — they are fully reliant on healthcare professionals, drugs, and technology. They have no choice. That’s where we can make a real difference. By providing advanced therapies and support to the professionals who treat them in the most crucial moments of their lives, we can give them the solutions that no one else is offering.”

Matthew M. Bennett - Senior Vice President Legal and Corporate Development

Matthew M. Bennett - Senior Vice President Legal and Corporate Development

"How many people can say they actually look forward to going to work in the morning? I feel fortunate to be part of this group. Working with a team of highly passionate people who strive to advance science beyond where it has ever been before is something that I am excited to be a part of."

James Briggs - Senior Vice President Human Resources

James Briggs - Senior Vice President Human Resources

"When people ask me what we do at Ikaria my answer is simple: People who work at Ikaria are here to do more than just a job. Our employees are a special group...from our scientists to our distribution associates."

Douglas Greene, MD - Executive Vice President Research and Development

Douglas Greene, MD - Executive Vice President Research and Development

"Only by listening to clinicians, understanding their needs, and observing their challenges firsthand can we fully respond to the complexities of critical care. Our development of therapies is constantly refined by our presence in, commitment to, and passion for this complex arena. Together, we will advance critical care to the next level."

Tasos G. Konidaris - Senior Vice President, Chief Financial Officer

Tasos G. Konidaris

"What makes Ikaria different from other companies is that we put words into action. Our goal is to advance critical care, so we invest about a quarter of our revenues in R&D. We also invest in education to improve care, and to fund research, all in the hopes that the quality of clinical research in the future will be in good hands."

Stephen Ross - Senior Vice President Commercial Operations

Stephen Ross - Senior Vice President Commercial Operations

"Having a clear, well-articulated corporate vision is important, but the true value of a company lies in its ability to make a difference in the lives of patients. To stand side-by-side with a respiratory therapist in a NICU and see a baby who was previously struggling to get enough oxygen turn a healthy pink color—that makes me so very proud of what we do."

Lien-Lung (L.L.) Sheu, PhD - Senior Vice President Global Manufacturing and Operations

Sheu Lien-Lung

“Maximizing the full scientific potential of a drug is obviously very important. With a reliable supply chain, the full therapeutic potential of Ikaria's products can be brought to critically ill patients—when time is of the essence. So we ask many practical questions like: ‘What can be done to more effectively deliver Ikaria drugs and delivery systems to patients in today’s hospital environment?’”

Joseph Stauffer, DO

Joseph Stauffer

"As a physician, I understand the deep impact INOMAX® has had on critical care clinicians and their patients. Our service model and our commitment to critical care ensure that this important therapy makes its way through all the ins and outs of the modern medical institution to the patient. We are deeply committed to ensuring that INOMAX is delivered safely, precisely, and effectively to each and every patient who needs it."